X
CERE

Xponance’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Xponance’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,638
Closed -$353K – 1405
2024
Q2 		$353K Buy
+8,638
New +$360K ﹤0.01% 1007

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Xponance's CERE Position: Q3 2024 in Review

Xponance sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 8,638 shares — an estimated $353K sold.

Xponance first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $353K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Xponance reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Xponance sold 8,638 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $353K.
  • Xponance first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Xponance's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $353K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Xponance's 13F filing for Q3 2024, filed 12 Nov 2024.